LA MALATTIA DI ALZHEIMER
Cos'č l'Alzheimer
Le cause
I segni clinici
I primi sintomi
Quando rivolgersi al medico
Stadi della malattia
I problemi pių frequenti
Come comportarsi con il malato
I disagi del familiare
Voce ai familiari
La posta del cervello
LA DIAGNOSI E LA CURA
Diagnosi precoce nell'Ambulatorio della Memoria
Farmaci e riabilitazione
I farmaci sperimentali
The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to collect imaging and biomarker data which would validate them for use in AD treatment trials. The overall goal of the Pilot E-ADNI project is to test the ability of European centres to (i) implement the US-ADNI data acquisition procedures and (ii) use them on the US-ADNI target groups (healthy aging , MCI, and Alzheimer's disease).
The aim of this pilot project is to demonstrate that the core ADNI methodology, i.e. standardized and centralized collection of MR imaging, clinical data, blood, and CSF samples can be adopted by European Centres of the European Alzheimer's Disease Consortium (EADC). Seven test sites and 9 subjects will be involved to collect data at a single timepoint. Once collected by the participating centres, data and specimens will be sent to central repositories.
For further information: gfrisoni@fatebenefratelli.it
DOWNLOADABLES
Pilot E-ADNI Proposal
MRI Protocols
Case Report Form
Biological Protocol
Publication Policy
Publications
Slides